by admin | May 11, 2026 | News & Opinions
By Yan Leyfman, MD – Cancer Network – Chimeric antigen receptor (CAR) T-cell therapy has fundamentally reshaped the treatment paradigm for hematologic malignancies, delivering durable remissions in diseases once defined by therapeutic resistance.¹ Yet,...
by admin | May 8, 2026 | News & Opinions
By Simon Spichak – Being Patient – A trial suggests a single infusion of stem cells may slow physical decline in older adults — but scientists disagree on why, or whether it works at all. As people age, they become more vulnerable to a range of health...
by admin | May 7, 2026 | News & Opinions
By Meagan Raeke – Penn Medicine – The first-of-its-kind Phase I clinical trial uses a CAR T cell therapy modeled after natural killer cells and designed to limit T cell exhaustion. SAN DIEGO – An innovative type of CAR T cell therapy, called KIR-CAR, was...
by admin | May 6, 2026 | News & Opinions
By Connie Zhi-Chen Hung • Tsai-Hua Chung • Wen-Hsien Lin – Cureus – Abstract Conventional treatments for deep second-degree scald burns are frequently associated with prolonged healing times and hypertrophic scarring. Exosomes derived from mesenchymal stem...
by admin | May 5, 2026 | News & Opinions
By Zara Abrams – Keck School of Medicine of USC – In a proof-of-concept study, a team of researchers from USC, Caltech and UC Irvine tested the full “bionic suit” with a patient for the first time, showing promising early results. Restoring both walking...
